Avricore Health Inc. (TSXV:AVCR)

Market Cap	7.09M -6.7%
Revenue (ttm)	1.92M -59.3%
Net Income	-1.63M
EPS	-0.02
Shares Out	101.29M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	40,230
Average Volume	97,618
Open	0.0650
Previous Close	0.0700
Day's Range	0.0650 - 0.0700
52-Week Range	0.0350 - 0.1000
Beta	0.19
RSI	51.14
Earnings Date	Apr 28, 2026

About Avricore Health

Avricore Health Inc. engages in the health data and point-of-care technologies business. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1996
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: AVCR

Financial Performance

In 2024, Avricore Health's revenue was 4.79 million, an increase of 37.32% compared to the previous year's 3.49 million. Losses were -668,977, -4.60% less than in 2023.